These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6354090)

  • 1. Polymerized allergens.
    Patterson R; Suszko IM
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):241-6. PubMed ID: 6354090
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential rates of allergen release: an important consideration in the preparation of allergenic extracts.
    Marsh DG
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1987; (80):47-57. PubMed ID: 3688873
    [No Abstract]   [Full Text] [Related]  

  • 3. Grass pollen hyposensitization versus placebo therapy.
    Weyer A; Heritier CL; David B
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):101-7. PubMed ID: 6354089
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of human IgE antibody responses in vivo.
    Adkinson NF; Creticos PS; Norman PS; Mardiney MR; Rosenberg GL; Hamilton RG; Van Metre TE
    Monogr Allergy; 1983; 18():69-74. PubMed ID: 6646139
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition.
    Hayek B; Vangelista L; Pastore A; Sperr WR; Valent P; Vrtala S; Niederberger V; Twardosz A; Kraft D; Valenta R
    J Immunol; 1998 Dec; 161(12):7031-9. PubMed ID: 9862740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic engineering of pollen allergens for hayfever immunotherapy.
    Bhalla PL
    Expert Rev Vaccines; 2003 Feb; 2(1):75-84. PubMed ID: 12901599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 9. One grass or many? Does allergy distinguish among species?
    Kleine-Tebbe J
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():65-7. PubMed ID: 19221623
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific immunotherapy with tablets].
    Krankenpfl J; 2005; 43(7-10):260. PubMed ID: 16515331
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
    Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
    Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
    [No Abstract]   [Full Text] [Related]  

  • 12. Study on specific immunotherapy with the aid of 3M Diagnostic Systems' tests.
    Stasiak-Barmuta A; Dabrowska I; Piotrowska T; Hofman J
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():53-6. PubMed ID: 1292848
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study on pollenosis].
    Ito K
    Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1502-8. PubMed ID: 1280671
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pollen-induced allergy. Programming and monitoring of specific immunotherapy].
    Obtułowicz K
    Folia Med Cracov; 1988; 29(1-2):21-48. PubMed ID: 3255656
    [No Abstract]   [Full Text] [Related]  

  • 15. Weed pollen allergens.
    Mohapatra SS; Lockey RF; Polo F
    Clin Allergy Immunol; 2008; 21():127-39. PubMed ID: 18828502
    [No Abstract]   [Full Text] [Related]  

  • 16. [Desensitization for those afflicted with hay fever. With 4 pricks hyposensitized to pollen].
    MMW Fortschr Med; 2004 Mar; 146(11):58. PubMed ID: 15152778
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymerized whole ragweed: Human safety and immune response.
    Kelly JF; Zeiss CR; Patterson R; Levitz D; Suszko IM
    J Allergy Clin Immunol; 1980 Jan; 65(1):50-6. PubMed ID: 6153084
    [No Abstract]   [Full Text] [Related]  

  • 18. Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double-blind, placebo-controlled clinical trial.
    Shamji MH; Ceuppens J; Bachert C; Hellings P; Placier G; Thirion G; Bovy N; Durham SR; Duchateau J; Legon T; Pirotton S
    J Allergy Clin Immunol; 2018 Jan; 141(1):448-451. PubMed ID: 29030102
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy.
    Ford SA; Baroody FM; Naclerio RM
    Rhinol Suppl; 1992; 14():52-6. PubMed ID: 1389403
    [No Abstract]   [Full Text] [Related]  

  • 20. A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases.
    Douladiris N; Savvatianos S; Roumpedaki I; Skevaki C; Mitsias D; Papadopoulos NG
    Int Arch Allergy Immunol; 2013; 162(2):163-72. PubMed ID: 23921568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.